Intrinsic Value of S&P & Nasdaq Contact Us

Atreca, Inc. BCEL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.00
+4344.4%

Stock Statistics — BCEL

Atreca, Inc. (BCEL) has a market capitalization of $3.57M and trades at $0.09. The 52-week range is 0.052-1.2.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-2.35, annual revenue of $770K.

The stock has a beta of 1.03, operates in the Healthcare sector.

Trading Data
Current Price$0.09
52-Week Range0.052-1.2
Volume122.12K
Avg Volume (30D)267K
Market Cap$3.57M
Beta (1Y)1.03
Company
IPO Date2019-06-20
Employees90
CEOJohn A. Orwin
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS04965G1094
CUSIP04965G109
Income (Latest Year)
Revenue$770K
Gross Profit$-6.31M
EBITDA$-90.44M
Operating Income$-103.79M
Net Income$-90.53M
EPS$-2.35
EPS Diluted$-2.35
Shares Outstanding$38.59M
Balance Sheet (Latest Year)
Total Assets$155.03M
Current Assets$78.03M
Cash & ST Investments$70.5M
Total Liabilities$76.62M
Total Debt$63.88M
Net Debt$33.06M
Total Equity$78.41M
Debt / Equity0.81
Valuation Ratios
P/E Ratio-0
P/S Ratio4.63
P/B Ratio0.05
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message